Australia markets open in 1 hour 35 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
122.60-3.32 (-2.64%)
At close: 04:00PM EDT
121.86 -0.74 (-0.60%)
After hours: 04:06PM EDT

Repligen Corporation

Building 1
Suite 100 41 Seyon Street
Waltham, MA 02453
United States
781 250 0111
https://www.repligen.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees1,783

Key executives

NameTitlePayExercisedYear born
Mr. Anthony J. HuntCEO & Director885kN/A1964
Mr. Olivier LoeillotPresident & Chief Commercial Officer1.49MN/A1970
Mr. Jason K. GarlandCFO & Chief Compliance Officer282.99kN/A1974
Mr. James R. BylundChief Operating Officer472.18kN/A1964
Ms. Christine GebskiSenior Vice President of Filtration & Chromatography396.09kN/A1968
Mr. Ralf KuriyelSenior Vice President of Research & Development401.74kN/A1958
Mr. Keith Lee RobinsonChief Information OfficerN/AN/AN/A
Ms. Sondra S. NewmanGlobal Head of Investor RelationsN/AN/AN/A
Ms. Kimberly A. CornwellGeneral Counsel & Global Head of LegalN/AN/AN/A
Mr. Neil WhitfieldVP & Global Head of SalesN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Corporate governance

Repligen Corporation’s ISS governance QualityScore as of 1 July 2024 is 2. The pillar scores are Audit: 9; Board: 3; Shareholder rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.